Testing for recombinant human erythropoietin in urine: problems associated with current anti-doping testing

Abstract

this study demonstrates a poor agreement in test results comparing two WADA-accredited laboratories. Moreover, after the initial rHuEpo boosting period the power to detect rHuEpo misuse during the maintenance and post periods appears minimal.